Cargando…
Satisfaction and experiences of patients taking fingolimod and involved in a pharmacy-based patient support program in Switzerland — a qualitative study
BACKGROUND: Fingolimod is an oral multiple sclerosis drug that is considered a specialty drug due to its high cost and safety issues. The Fingolimod Patient Support Program (F-PSP) is a specialty pharmacy service developed to ensure the responsible use of fingolimod by promoting patient safety and m...
Autores principales: | Bourdin, Aline, Dubois, Julie, Foley, Rose-Anna, Schluep, Myriam, Bugnon, Olivier, Berger, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227186/ https://www.ncbi.nlm.nih.gov/pubmed/32410681 http://dx.doi.org/10.1186/s12913-020-05278-3 |
Ejemplares similares
-
Longitudinal analysis of safety and medication adherence of patients in the Fingolimod patient support program: a real-world observational study
por: Bourdin, Aline, et al.
Publicado: (2021) -
Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland
por: Lelubre, Mélanie, et al.
Publicado: (2015) -
The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland
por: Leuthold, Claudine, et al.
Publicado: (2018) -
Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis
por: Perraudin, Clémence, et al.
Publicado: (2020) -
Treatment satisfaction and quality of life in patients treated with fingolimod
por: Mékiès, Claude, et al.
Publicado: (2018)